Neoplasms
|
0.100 |
AlteredExpression
|
group |
BEFREE |
In a detailed molecular pathological analysis of a series of epididymides collected from VHL patients at autopsy, we found that ECAs are true neoplasms that arise secondary to inactivation of the wild-type copy of the VHL gene, followed by early and simultaneous activation of HIF1 and HIF2 associated with up-regulation of downstream targets, including CAIX and GLUT-1.
|
16841375 |
2006 |
Neoplasms
|
0.100 |
AlteredExpression
|
group |
BEFREE |
We screened the mRNA expression of tumor-associated antigens (TAAs) from the literature (fibromodulin, survivin, OFA-iLRP, BAGE, G250, MAGE1, PRAME, proteinase, syntaxin, hTERT, WT-1) and TAAs defined previously by serological analysis of cDNA expression libraries from leukemic cells (PINCH, HSJ2, MAZ, MPP11, RHAMM/CD168, NY-Ren60).
|
16773189 |
2006 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
All patients were originally enrolled in an institutional review board-approved study assessing the role of a reverse-transcriptase polymerase chain reaction peripheral blood assay designed to detect the tumor-specific gene carbonic anhydrase-9 (CA9).
|
16698354 |
2006 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
Hsp110 + CA9 decreased tumor growth compared to control vaccinations.
|
17146628 |
2007 |
Neoplasms
|
0.100 |
AlteredExpression
|
group |
BEFREE |
The expression levels of CA9 and VEGF were significantly higher in the tumors of post- as opposed to pre-menopausal patients.
|
17342330 |
2007 |
Neoplasms
|
0.100 |
AlteredExpression
|
group |
BEFREE |
Renal tumour subtype/nephron segment-specific gene expression detected by RQ-PCR demonstrated that the tumour expressed relatively high amounts of alpha-methylacyl-CoA racemase (AMACR) and the KIT oncogene, but relatively low amounts of carbonic anhydrase IX (CA9), aquaporin 1 (AQP1), claudin 7 (CLDN7), parvalbumin (PVALB), chloride channel Kb (CLCNKB) and 11-beta-hydroxysteroid dehydrogenase 2 (HSD11B2), suggesting diverse mRNA signatures.
|
17323425 |
2007 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
Tissue specimens were obtained from 20 patients who were evaluable for both tumor response and staining for phospho-S6 and carbonic anhydrase IX.
|
17956710 |
2007 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
The hypoxia-inducible enzyme carbonic anhydrase IX (CA IX) has recently been discussed as a surrogate marker of tumor hypoxia, an indicator of prognosis and a potential therapeutic target in malignant glioma.
|
16944313 |
2007 |
Neoplasms
|
0.100 |
AlteredExpression
|
group |
BEFREE |
Tumor hypoxia was estimated by evaluating the expression of the hypoxia-regulated gene HIF-1alphaand its target gene carbonic anhydrase IX (CA-IX).
|
17359291 |
2007 |
Neoplasms
|
0.100 |
AlteredExpression
|
group |
BEFREE |
Tumor carbonic anhydrase 9 expression is associated with the presence of lymph node metastases in uterine cervical cancer.
|
17233814 |
2007 |
Neoplasms
|
0.100 |
AlteredExpression
|
group |
BEFREE |
Examples include plasma VEGF levels, VHL gene mutation status and carbonic anhydrase IX levels in tumor tissue, among others.
|
18062748 |
2007 |
Neoplasms
|
0.100 |
GeneticVariation
|
group |
BEFREE |
A tumor targeted gene vector modified with G250 monoclonal antibody for gene therapy.
|
18316136 |
2008 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
Tumor-associated carbonic anhydrase 9 spatially coordinates intracellular pH in three-dimensional multicellular growths.
|
18482982 |
2008 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
Herein, we modified a flow cytometry protocol to separate NDRG1- and CA-IX-negative and -positive cells in vitro to sort chronically hypoxic cells from glioblastoma tumors.
|
18636206 |
2008 |
Neoplasms
|
0.100 |
AlteredExpression
|
group |
BEFREE |
Immunohistochemistry, high expression of CA9 was found in 63 of the 127 primary tumour specimens and was correlated with poor outcome (P=0.0003) and more aggressive/less favourable clinicopathological parameters (tumour size (P=0.0235), tumour depth (P<0.0001), regional lymph node metastasis (P=0.0031), distant lymph node metastasis (P=0.0077), stage (P<0.0001) and blood vessel invasion (P=0.006)).
|
18841153 |
2008 |
Neoplasms
|
0.100 |
AlteredExpression
|
group |
BEFREE |
Low CAIX expression and absence of VHL mutation were associated with a more advanced tumors e.g., higher T stages and presence of metastases.
|
18464292 |
2008 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
There was no relationship between HPV status and tumor pO(2) or CAIX staining.
|
19427557 |
2009 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
Study of tumors from patients treated with interleukin-2 (IL-2) has suggested that response was unlikely in patients with tumors with papillary features or low carbonic anhydrase IX (CAIX) expression.
|
19402069 |
2009 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
Crystal structure of the catalytic domain of the tumor-associated human carbonic anhydrase IX.
|
19805286 |
2009 |
Neoplasms
|
0.100 |
AlteredExpression
|
group |
BEFREE |
Transcriptional control of the tumor- and hypoxia-marker carbonic anhydrase 9: A one transcription factor (HIF-1) show?
|
19344680 |
2009 |
Neoplasms
|
0.100 |
AlteredExpression
|
group |
BEFREE |
TGF-beta upregulates tumor-associated carbonic anhydrase IX gene expression in Hep3B cells.
|
19540352 |
2009 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
Expression of CAIX and CAXII proteins in tumor tissues is primarily induced by hypoxia and this is particularly true for CAIX, which is regulated by the transcription factor, hypoxia inducible factor-1 (HIF-1).
|
19291313 |
2009 |
Neoplasms
|
0.100 |
AlteredExpression
|
group |
BEFREE |
In the cervix, carbonic anhydrase IX (CA-IX) is expressed in cervical neoplasia, but rarely in the benign cervix.
|
19670419 |
2009 |
Neoplasms
|
0.100 |
AlteredExpression
|
group |
BEFREE |
The monoclonal antibody M75 was used to evaluate CAIX protein expression in the primary tumor by immunohistochemistry.
|
19539328 |
2009 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
Our results suggest that CO(2)-producing tumors may express CA9 to facilitate CO(2) excretion, thus raising pH(i) and reducing pH(e), which promotes tumor proliferation and survival.
|
19458084 |
2009 |